Evaluation of vitamin D levels among HIV-infected patients in New York City

AIDS Research and Human Retroviruses

Volumn 28, Issue 3, 2012, Pages 235-241

  Kim, Jong Hun ^a   Gandhi, Vani ^b,c   Psevdos, George ^b,c   Espinoza, Fabiola ^d   Park, Joyce ^b   Sharp, Victoria ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^c Columbia University College of Physicians and Surgeons ^*  (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D;

ADULT; AFRICAN AMERICAN; ARTICLE; CITY; DISEASE ASSOCIATION; ETHNICITY; EUROPEAN AMERICAN; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RETROSPECTIVE STUDY; UNITED STATES; VIREMIA; VIRUS LOAD; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 84863278380     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0040     Document Type: Article

References (29)

1. DeLuca HF: Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004;80(6 Suppl): 1689S-1696S
2. Holick MF: Vitamin D deficiency. N Engl J Med 2007;357(3): 266-281.
3. Dusso AS, Brown AJ, and Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol 2005;289(1):F8-28.
4. Adams JS and Hewison M: Unexpected actions of vitamin D: New perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008;4(2):80-90. (Pubitemid 351156900)
5. Penna G, Roncari A, Amuchastegui S, et al.: Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4+Foxp3+ regulatory T cells by 1,25-dihydroxyvitamin D3. Blood 2005;106(10):3490-3497. (Pubitemid 41609185)
6. Liu PT, Stenger S, Li H, et al.: Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006;311(5768):1770- 1773.
7. Shah SS, McGowan JP, Smith C, et al.: Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis 2002;35(10):1238-1243. (Pubitemid 35305872)
8. Harrison KM, Song R, and Zhang X: Life expectancy after HIV diagnosis based on national HIV surveillance data from 25 states, United States. J Acquir Immune Defic Syndr 2010;53(1):124-130.
9. Panel on Antiretroviral Guidelines for Adults and Adolescents: Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 10, 2011; 1-166. Available at http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdo-lescentGL.pdf.
10. Brown TT and McComsey GA: Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D. Antivir Ther 2010;15(3):425-429.
11. Rosenvinge MM, Gedela K, Copas AJ, et al.: Tenofovir-linked hyperparathyroidism is independently associated with the presence of vitamin D deficiency. J Acquir Immune Defic Syndr 2010;54(5):496-9.
12. Cozzolino M, Vidal M, Arcidiacono MV, et al.: HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydrox-yvitamin D. AIDS 2003;17(4):513-520. (Pubitemid 36293104)
13. Heaney RP, Dowell MS, Hale CA, et al.: Calcium absorption varies within the reference range for serum 25-hydro-xyvitamin D. J Am Coll Nutr 2003;22(2):142-146. (Pubitemid 36417827)
14. Bischoff-Ferrari HA, Willett WC, Wong JB, et al.: Prevention of nonvertebral fractures with oral vitamin D and dose dependency: A meta-analysis of randomized controlled trials. Arch Intern Med 2009;169(6):551-561.
15. Giovannucci E, Liu Y, Hollis BW, et al.: 25-Hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med 2008;168(11):1174-1180. (Pubitemid 351831400)
16. Lappe JM, Travers-Gustafson D, Davies KM, et al.: Vitamin D and calcium supplementation reduces cancer risk: Results of a randomized trial. Am J Clin Nutr 2007;85(6):1586-1591. (Pubitemid 46890428)
17. Souberbielle JC, Body JJ, Lappe JM, et al.: Vitamin D and musculoskeletal health, cardiovascular disease, autoimmu-nity and cancer: Recommendations for clinical practice. Autoimmun Rev 2010;9(11):709-715.
18. Wasserman P and Rubin DS: Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIV-infected men under care. AIDS Patient Care STDS 2010;24(4):223-227.
19. Van Den Bout-Van Den Beukel CJ, Fievez L, Michels M, et al.: Vitamin D deficiency among HIV type 1-infected individuals in the Netherlands: Effects of antiretroviral therapy. AIDS Res Hum Retroviruses 2008;24(11):1375-1382.
20. Rodríguez M, Daniels B, Gunawardene S, et al.: High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res Hum Retroviruses 2009;25(1):9-14.
21. Mueller NJ, Fux CA, Ledergerber B, et al.: High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS 2010;24(8):1127-1134.
22. Welz T, Childs K, Ibrahim F, et al.: Efavirenz is associated with severe vitamin D deficiency and increased alkaline phosphatase. AIDS 2010;24(12):1923-1928.
23. Mehta S, Giovannucci E, Mugusi FM, et al.: Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS One 2010;5(1):e8770.
24. Anselmi A, Vendrame D, Rampon O, et al.: Immune recon-stitution in human immunodeficiency virus type 1-infected children with different virological responses to anti-retrovi-ral therapy. Clin Exp Immunol 2007;150(3):442-450 (Pubitemid 350098747)
25. Brenchley JM and Douek DC: The mucosal barrier and immune activation in HIV pathogenesis. Curr Opin HIV AIDS 2008;3(3):356-361. (Pubitemid 351521021)
26. Beignon AS, McKenna K, Skoberne M, et al.: Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions. J Clin Invest 2005;115(11):3265-3275. (Pubitemid 41567591)
27. Edfeldt K, Liu PT, Chun R, et al.: T-cell cytokines differentially control human monocyte antimicrobial responses by regulating vitamin D metabolism. Proc Natl Acad Sci USA 2010;107(52):22593-22598.
28. Childs KE, Fishman SL, Constable C, et al.: Inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users. AIDS Res Hum Retroviruses 2010;26(8):855-859.
29. Clemens TL, Adams JS, Henderson SL, et al.: Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982;1(8263):74-76. (Pubitemid 12248649)